Literature DB >> 25088422

Characterization of dual PTEN and p53-targeting microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic locus.

Yvonne Tay1, Shen Mynn Tan2, Florian A Karreth1, Judy Lieberman2, Pier Paolo Pandolfi3.   

Abstract

Tumor suppressor genes (TSGs) are often concomitantly lost or mutated in human cancers and have been shown to act synergistically to promote tumorigenesis. In addition to genomic alterations, posttranscriptional regulation by microRNAs (miRNAs) represents another mechanism by which TSG expression is dysregulated in cancers. Although miRNAs that target critical TSGs such as PTEN or p53 have been identified, little is known about miRNAs that concomitantly regulate both these key TSGs. In this study, we characterize microRNA 518c(∗) (miR-518c(∗)) and miR-638 as dual PTEN- and p53-targeting miRNAs that are upregulated in multiple human cancers. We focus on miR-638 and show that it associates independently with these two tumor suppressor transcripts as well as BRCA1, a known miR-638 target. We find that miR-638 overexpression promotes tumorigenesis and demonstrate cooperativity between miR-638 and its host gene Dnm2, suggesting that the Dnm2 locus encodes two distinct oncogenic components that play important roles in tumorigenesis.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088422      PMCID: PMC4128194          DOI: 10.1016/j.celrep.2014.06.064

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  41 in total

Review 1.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.

Authors:  David P Bartel; Chang-Zheng Chen
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

2.  A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

Authors:  Kevin C Miranda; Tien Huynh; Yvonne Tay; Yen-Sin Ang; Wai-Leong Tam; Andrew M Thomson; Bing Lim; Isidore Rigoutsos
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

3.  BRCA1 physically associates with p53 and stimulates its transcriptional activity.

Authors:  H Zhang; K Somasundaram; Y Peng; H Tian; H Zhang; D Bi; B L Weber; W S El-Deiry
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

4.  Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells.

Authors:  S Altiok; D Batt; N Altiok; A Papautsky; J Downward; T M Roberts; H Avraham
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.

Authors:  Daniel J Freeman; Andrew G Li; Gang Wei; Heng-Hong Li; Nathalie Kertesz; Ralf Lesche; Andrew D Whale; Hilda Martinez-Diaz; Nora Rozengurt; Robert D Cardiff; Xuan Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.

Authors:  Lindsey D Mayo; Jack E Dixon; Donald L Durden; Nickolas K Tonks; David B Donner
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

7.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

8.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

9.  Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

Authors:  W B Isaacs; B S Carter; C M Ewing
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity.

Authors:  Wassim Abou-Kheir; Paul G Hynes; Philip Martin; Juan Juan Yin; Yen-Nien Liu; Victoria Seng; Ross Lake; Joshua Spurrier; Kathleen Kelly
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

View more
  21 in total

1.  The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy.

Authors:  Xin Chen; Yun-Qian Gao; Yan-Yan Zheng; Wei Wang; Pei Wang; Juan Liang; Wei Zhao; Tao Tao; Jie Sun; Lisha Wei; Yeqiong Li; Yuwei Zhou; Zhenji Gan; Xuena Zhang; Hua-Qun Chen; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis.

Authors:  Weikang Ye; Jieke Li; Guan Fang; Xiupeng Cai; Yan Zhang; Chaojun Zhou; Lei Chen; Wenjun Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

3.  miR-497 plays a key role in Tanshinone IIA-attenuated proliferation in OCI-AML3 cells via the MAPK/ERK1/2 pathway.

Authors:  Hongyang Kang; Changqing Tong; Chaonan Li; Jianmin Luo
Journal:  Cytotechnology       Date:  2020-03-11       Impact factor: 2.058

4.  Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Authors:  Victoria Stepanova; Konstantin V Dergilev; Kelci R Holman; Yelena V Parfyonova; Zoya I Tsokolaeva; Mimi Teter; Elena N Atochina-Vasserman; Alla Volgina; Sergei V Zaitsev; Shane P Lewis; Fedor G Zabozlaev; Kseniya Obraztsova; Vera P Krymskaya; Douglas B Cines
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

Review 5.  Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia.

Authors:  Mariangela Morlando; Monica Ballarino; Alessandro Fatica
Journal:  Front Med (Lausanne)       Date:  2015-04-14

Review 6.  Clinical significance of microRNAs in chronic and acute human leukemia.

Authors:  Chien-Hung Yeh; Ramona Moles; Christophe Nicot
Journal:  Mol Cancer       Date:  2016-05-14       Impact factor: 27.401

Review 7.  MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.

Authors:  Matthew L Potter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

8.  MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells.

Authors:  Yunlan Tang; Yi Lin; Chuang Li; Xunwu Hu; Yi Liu; Mingyang He; Jun Luo; Guihong Sun; Tao Wang; Wenxin Li; Mingxiong Guo
Journal:  Cell Biosci       Date:  2015-09-25       Impact factor: 7.133

Review 9.  Regulation of Mutant p53 Protein Expression.

Authors:  Reshma Vijayakumaran; Kah Hin Tan; Panimaya Jeffreena Miranda; Sue Haupt; Ygal Haupt
Journal:  Front Oncol       Date:  2015-12-17       Impact factor: 6.244

Review 10.  A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target.

Authors:  Delphine Trochet; Marc Bitoun
Journal:  J Exp Clin Cancer Res       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.